Ming Shan

机构：Anhui Medical University, First Affiliated Hospital of Anhui Medical University · ORCID：0000-0002-9495-1645

发表论文 131 篇 · 总被引 2459 次 · h-index 27

代表论文

• Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription (2022 · Journal of Experimental & Clinical Cancer Research · 被引 73)
• Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (2022 · Nature Cancer · 被引 29)
• The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients (2024 · Clinical & Translational Oncology · 被引 16)
• Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II–III triple negative breast cancer: a retrospective analysis (2024 · Journal of Cancer Research and Clinical Oncology · 被引 9)
• Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast‐enhanced ultrasound and dynamic contrast‐enhanced magnetic resonance imaging (2022 · Cancer Medicine · 被引 9)
• Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis (2022 · Frontiers in Oncology · 被引 8)